Obstetrics & Gynaecology · Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia)

Which of the following best describes the mechanism of action of methyldopa in pregnancy-induced hypertension?

  • A Direct arteriolar vasodilatation via potassium channel opening
  • B Competitive antagonism of peripheral alpha-1 receptors
  • C False neurotransmitter action reducing central sympathetic outflow
  • D Inhibition of catechol-O-methyl transferase in adrenergic terminals
Correct answer: C. False neurotransmitter action reducing central sympathetic outflow

Explanation

Methyldopa is converted to alpha-methyl noradrenaline, a false neurotransmitter that is stored and released from central adrenergic neurons, stimulating inhibitory alpha-2 receptors and lowering sympathetic outflow. Its long safety record for mother and fetus makes it a traditional first-line oral agent in India, though sedation, dry mouth, depression and positive Coombs test limit use. It causes no uteroplacental flow compromise.

Reference: Katzung Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia) MCQs

See all Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia) MCQs →